A double-blind, placebo-controlled, randomized trial of XP-828L (800 mg) on the quality of life and clinical symptoms of patients with mild-to-moderate psoriasis.(Original Research)

Alternative Medicine Review | June 1, 2008| | Copyright

Abstract

In a placebo-controlled clinical trial, the dietary supplement XP-828L (commercialized as Dermylex[TM]) demonstrated potential to reduce symptoms associated with mild-to-moderate psoriasis at a dose regimen of 5 g daily for 56 days. However, recent in vivo data in humans and animals suggest a daily dose of 800 mg could be more efficient than a 5-g dose. However, no well-structured clinical study has confirmed this hypothesis. The goal of the present study is to examine the effect of XP-828L at a daily dose of 800 mg on the quality of life and disease ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Galen Holdings PLC to Acquire Warner Chilcott PLC; Nasdaq Listing of Galen.
PR Newswire ; ...of Warner Chilcott (Nasdaq: WCRX) and Galen (LSE: GAL) announce today that they...will become a wholly owned subsidiary of Galen. The acquisition is to be effected by...Ireland. Under the Transaction Agreement, Galen proposes to issue 2.5 new Galen shares...
Galen Holdings PLC Disposal of UK Businesses.
PR Newswire ; Galen Holdings PLC , ("Galen"), the specialty pharmaceutical company, today announces that...control of Dr. Allen McClay, the founder and a former Chairman of Galen. In a separate transaction Galen also today announces an agreement...
Galen's life and contributions
Magazine article from: The American Surgeon ; ...nothing is worth nothing"-Moses. CLAUDIUS GALEN (129-210 AD) is surely one of the most...medicine so they could be made useful.1 Galen was the originator of the experimental...unquestioned for 15 centuries. Claudius Galen was born in Pergamon in 129 AD. This was...
Galen Partners Closes $250 Million Fund.
PR Newswire ; Galen Partners V to Provide Expansion Capital to...STAMFORD, Conn., July 11 /PRNewswire/ -- Galen Partners, a leading private equity firm...today announced the close of its fifth fund, Galen Partners V, L.P. with $250 million in...
Galen Announces Acquisition of Pfizer Manufacturing Facility in Puerto Rico.
PR Newswire ; Galen Holdings PLC ("Galen") , today announced that Warner Chilcott Company, Inc., its wholly...manufactures a range of products, including certain products that Galen purchased from Pfizer in 2003. Under the terms of a transitional supply...
Galen's value jumps with American seal of approval.(Business)
Newspaper article from: The News Letter (Belfast, Northern Ireland) ; Byline: ADRIENNE McGILL THE value of Galen Holdings leapt $60 million yesterday following...labelling before launching in the US. Galen chief executive Roger Boissonneault called...approval is a great achievement for the Galen team, both in the US and Northern Ireland...
Galen Holdings PLC Receives Approvable Letter for Intravaginal Ring from FDA.
PR Newswire ; Galen Holdings PLC , the international pharmaceutical...Commenting on the announcement, Roger Boissonneault, Galen's Chief Executive, said: "This approval is a great achievement for the Galen team, both in the US and Northern Ireland. The...
Galen Announces Exercise of Option to Acquire Ovcon ANDA From Barr.
PR Newswire ; Galen Holdings PLC ("Galen") today announced that it has acquired an exclusive licence for a generic version of Galen's Ovcon(R) 35 oral contraceptive from Barr Laboratories, Inc...
Galen Holdings PLC ('Galen') Sale of Chemical Synthesis Services ('CSS').
PR Newswire ; ...Northern Ireland and ROCKAWAY, N.J. -- Galen Holdings PLC , the international specialty...McClay, the founder and former President of Galen, for a cash consideration of approximately...transaction will be used to further strengthen Galen's pharmaceutical business. CSS is part...
Galen Announces Patent for Chewable Oral Contraceptives.
PR Newswire ; Galen Holdings PLC ("Galen") , today announced that a patent has been issued by the United States...in November 2003. U.S. Patent No. 6,667,050 was issued to Galen (Chemicals) Limited, a wholly-owned subsidiary of Galen. The...

Find more facts and information related to the article "A double-blind, placebo-controlled, randomized ..."